These findings not only surpass existing GLP-1 therapies but also represent a new standard in pharmacological obesity management
Effective management requires individualized dose escalation, patient education, and nonpharmacologic strategies
Results Release of GLP-1 by glucose application alleviates heat sensitivity Given the essential role that GLP-1 plays in regulating glucose levels in the body, we primarily utilized intraperitoneal glucose administration and assessed changes in heat sensitivity in mice via hot plate tests
We make sure members get the right support, the right medication, and real results that last
Robust improvement in glycaemic control (HbA1c) in people with type 2 diabetes, with dose-dependent reductions observed in clinical trials
Report any suspected side effects to your healthcare professional and consider using the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk)